½ÃÀ庸°í¼­
»óǰÄÚµå
1789546

¼¼°èÀÇ ¾çÀÚ¼± Ä¡·á ½ÃÀå : ¼³Ä¡ À¯Çüº°, ÀûÀÀÁõº°, Áö¿ªº°

Proton Therapy Market, By Set up Type, By Indication, and By Region

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¾çÀÚ¼± Ä¡·á ½ÃÀåÀº 2025³â¿¡ 35¾ï 2,810¸¸ ´Þ·¯, 2032³â¿¡´Â 83¾ï 20¸¸ ´Þ·¯¿¡ À̸£°í, 2025-2032³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 13.0%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 35¾ï 2,810¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â 13.00% 2032³â ±Ý¾× ¿¹Ãø 83¾ï 20¸¸ ´Þ·¯

¾ç¼ºÀÚ Ä¡·á´Â ¹æ»ç¼± Ä¡·áÀÇ ÀÏÁ¾À¸·Î, °íÃâ·Â ¿¡³ÊÁö¸¦ »ç¿ëÇÏ¿© ¾ÏÀ̳ª ƯÁ¤ ºñ¾Ï Á¾¾çÀ» Ä¡·áÇÏ´Â ¹æ»ç¼± Ä¡·áÀÇ ÀÏÁ¾ÀÔ´Ï´Ù. X¼±À» ÀÌ¿ëÇÑ ¹æ»ç¼± Ä¡·á´Â Á¾¾ç¼¼Æ÷³ª ¾Ï¼¼Æ÷ µîÀÇ ÁúȯÀ» Ä¡·áÇϱâ À§ÇØ ¿À·§µ¿¾È »ç¿ëµÇ¾î ¿Ô½À´Ï´Ù. ¾ç¼ºÀÚ Ä¡·á´Â ¾çÀüÇϸ¦ ¶í ÀÔÀÚ(¾ç¼ºÀÚ)ÀÇ ¿¡³ÊÁö¸¦ »ç¿ëÇÕ´Ï´Ù. ¾Ç¼º Á¾¾ç»Ó¸¸ ¾Æ´Ï¶ó ºñ¾Ï¼º Á¾¾ç Ä¡·á¿¡µµ »ç¿ëµË´Ï´Ù. ¾ç¼ºÀÚ¼± Ä¡·á´Â Áúº´ Ä¡·á¿¡ »ç¿ëÇϰųª ¼ö¼ú, È­Çпä¹ý µî ´Ù¸¥ Ä¡·á¿Í º´ÇàÇØ¾ß ÇÕ´Ï´Ù. ÀϹÝÀûÀÎ X-¼± ¹æ»ç¼±À» Á¶»çÇØµµ ¾ÏÀÌ ³²¾ÆÀְųª Àç¹ßÇÏ´Â °æ¿ì¿¡´Â ¾ç¼ºÀÚ¼± Ä¡·á¸¦ ½ÃÇàÇϱ⵵ ÇÕ´Ï´Ù. ¾ç¼ºÀÚ¼± Ä¡·á´Â ³úÁ¾¾ç, À°Á¾, Àü¸³¼±¾Ï, ¼Ò¾Æ¾Ï, ÃéÀå¾Ï µî ´Ù¾çÇÑ ¾Ï Ä¡·á¿¡ »ç¿ëµÇ±âµµ ÇÕ´Ï´Ù. ÀÌ Ä¡·á¹ýÀº Ç¥Àû ¾Ï¼¼Æ÷³ª Á¾¾ç¼¼Æ÷¿¡ °í¿¡³ÊÁö ¹æ»ç¼±À» Á¤È®ÇÏ°Ô Á¶»çÇÏ´Â Ä¡·á¹ýÀÔ´Ï´Ù. ¾Ï ¿¬±¸¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡´Â ½ÃÀå ÁøÃâ±â¾÷µé¿¡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ, ¾ç¼ºÀÚ Ä¡·á¸¦ Á¦°øÇÏ´Â ÀÇ·á½Ã¼³ Áõ°¡µµ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå ¿ªÇÐ

ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷µéÀº Á¦ÈÞ, Àμö µî ¼ºÀå Àü·«¿¡ ÁýÁßÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¼¼°è ¾ç¼ºÀÚ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾Ï ȯÀÚ ¹× ÀÇ·á½Ã¼³ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 8¿ù ÀÇ·á ±â¼ú ±â¾÷ IBA(Ion Beam Applications)´Â ´ÙÇÐÁ¦ ÀÇ·á ±â°üÀÎ Apollo Hospitals Enterprise Ltd(AHEL)¿Í ¾Æ½Ã¾Æ Áö¿ªÀÇ IBA °í°´À» À§ÇÑ ¾ç¼ºÀÚ Ä¡·á ±³À° ¹× ÈÆ·Ã ÇÁ·Î±×·¥À» Á¦°øÇϱâ À§ÇØ ±³À° ÇÁ·Î±×·¥ Á¦°øÀ» À§ÇÑ Çù·Â °è¾àÀ» ü°áÇß´Ù°í ¹àÇû½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ ¾ç¼ºÀÚ¼± Ä¡·á ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© 2025-2032³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»ç ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
  • ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ Ã¢Ãâ ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.
  • ¼¼°è ¾ç¼ºÀÚ Ä¡·á ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ±â¾÷ ¼Ò°³, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä Æ¯Â¡, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î Á¤¸®ÇÏ¿© ¼ö·ÏÇÏ¿´½À´Ï´Ù.
  • ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä ±â¾÷À¸·Î´Â Hitachi, Ion Beam Applications SA, Mevion Medical Systems, Mitsubishi Electric Corporation, Provision Healthcare, ProTom International, Sumitomo Heavy Machinery Industry, Barian Medical Systems, Optivus Proton Therapy, Inc. µîÀÌ ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
  • ¼¼°è ¾ç¼ºÀÚ Ä¡·á ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¾ç¼ºÀÚ Ä¡·á ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¿µÇ⠺м®
  • ÃÖ±Ù Á¦Ç° ¸±¸®½º
  • ¿ªÇÐ
  • ÇÕº´, Àμö, Á¦ÈÞ
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • PEST ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ¾çÀÚ¼± Ä¡·á ½ÃÀå, ¼³Ä¡ À¯Çüº°, 2020-2032³â

  • ¼­·Ð
  • ´ÜÀÏ ·ë
  • ¸ÖƼÇà ·ë

Á¦5Àå ¼¼°èÀÇ ¾çÀÚ¼± Ä¡·á ½ÃÀå, ÀûÀÀÁõº°, 2020-2032³â

  • ¼­·Ð
  • µÎ°æºÎ¾Ï
  • À°Á¾
  • ¼Ò¾Æ¾Ï
  • À§Àå¾Ï
  • Àü¸³¼±¾Ï
  • Æó¾Ï

Á¦6Àå ¼¼°èÀÇ ¾çÀÚ¼± Ä¡·á ½ÃÀå, Áö¿ªº°, 2020-2032³â

  • ¼­·Ð
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ASEAN ±¹°¡
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
    • GCC ±¹°¡
    • À̽º¶ó¿¤
    • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • Áß¾Ó¾ÆÇÁ¸®Ä«
    • ºÏ¾ÆÇÁ¸®Ä«

Á¦7Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • Hitachi Ltd.
    • Ion Beam Applications SA
    • Mevion Medical Systems
    • Mitsubishi Electric Corporation
    • Provision Healthcare
    • Protom International
    • Sumitomo Heavy Industries Ltd.
    • Varian Medical Systems, Inc.
    • Optivus Proton Therapy, Inc.
    • Advanced Oncotherapy plc.

Á¦8Àå ¼½¼Ç

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
LSH 25.08.19

Proton Therapy Market is estimated to be valued at USD 3,528.1 Mn in 2025 and is expected to reach USD 8,300.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3,528.1 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.00% 2032 Value Projection: USD 8,300.2 Mn

Proton therapy is a type of radiation therapy that uses high-power energy to treat cancer and certain non-cancerous tumors. Radiation therapy using X-rays has long been used to treat the conditions such as tumor cell or cancer cells. Proton therapy uses energy from positively charged particles (protons). It is used to treat non-cancerous tumors as well as malignancy. Proton therapy must be used to treat the illness, or it must be combined with other treatments like surgery and chemotherapy. If the cancer is still present or returns after conventional X-ray radiation, proton treatment may also be employed. Proton therapy is sometimes used to treat various cancers such as brain tumors, sarcoma, prostate cancer, pediatric cancer, and pancreatic cancer. The therapy utilizes a precision dose of high-energy radiation in the target cancer cells and tumor cells. Increasing funding for cancer research is expected to offer lucrative growth opportunities for market players. Furthermore, the increasing number of healthcare facilities offering proton therapy is also expected to drive market growth.

Market Dynamics

The key market players are focused on adopting growth strategies, such as collaboration and acquisitions, which is anticipated to fuel the global proton therapy market growth. The increasing number of cancer patients and healthcare facilities is expected to boost the market growth. For instance, in August 2022, IBA (Ion Beam Applications), a medical technology company, announced that it had signed a collaboration agreement with Apollo Hospitals Enterprise Ltd (AHEL), a multispecialty health care unit, to provide proton therapy training and education programs for IBA customers in Asia.

Key features of the study

  • This report provides an in-depth analysis of the global proton therapy market and provides market size (USD Mn) and Compound Annual Growth Rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global proton therapy market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies.
  • The key companies covered as a part of this study include Hitachi Ltd., Ion Beam Applications SA, Mevion Medical Systems, Mitsubishi Electric Corporation, Provision Healthcare, ProTom International, Sumitomo Heavy Industries, Varian Medical Systems, Optivus Proton Therapy, Inc., and Advanced Oncotherapy plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global proton therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global proton therapy market.

Market Segmentation

  • Global Proton Therapy Market, By Set-up Type
    • Single Room
    • Multiple Room
  • Global Proton Therapy Market, By Indication
    • Head & Neck Cancer
    • Sarcoma
    • Pediatric Cancer
    • Gastro-intestinal Cancer
    • Prostate Cancer
    • Lung Cancer
  • Global Proton Therapy Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
    • Hitachi Ltd.
    • Ion Beam Applications SA
    • Mevion Medical Systems
    • Mitsubishi Electric Corporation
    • Provision Healthcare
    • Protom International
    • Sumitomo Heavy Industries
    • Varian Medical Systems
    • Optivus Proton Therapy, Inc.
    • Advanced Oncotherapy plc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Setup Type
    • Market Snippet, By Indication
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Recent Product Launches
    • Epidemiology
    • Mergers, Acquisitions, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis

4. Global Proton Therapy Market, By Set up Type, 2020-2032 (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Single Room
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Multiple Room
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Proton Therapy Market, By Indication, 2020-2032 (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Head & Neck Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Sarcoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Pediatric Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Gastro-intestinal Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Lung Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Proton Therapy Market, By Region, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region 2021-2032
  • North America
    • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Country, 2020-2032, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Country, 2020-2032, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Country, 2020-2032, (USD Mn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Country, 2020-2032, (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Country, 2020-2032, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020-2032, (USD Mn)
      • South Africa
      • Central Africa
      • North Africa

7. Competitive Landscape

  • Company Profiles
    • Hitachi Ltd.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Ion Beam Applications SA
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Mevion Medical Systems
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Mitsubishi Electric Corporation
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Provision Healthcare
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Protom International
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Sumitomo Heavy Industries Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Varian Medical Systems, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Optivus Proton Therapy, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Advanced Oncotherapy plc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦